Research Publications

    1. Long-Term survival across breslow thickness categories: Findings from a Population-Based study of 210,042 Australian melanoma patients. Lo SN, Williams GJ, Cust AE, Varey AHR, Ch’ng S, Scolyer RA, Thompson JF. J Natl Cancer Inst. 2024 Sep 9:djae198. doi: 10.1093/jnci/djae198. Online ahead of print. PMID: 39245462

    2. Comparison of clinicopathological features and treatment outcomes for cutaneous melanomas of the head and neck and melanomas arising at other sites: implications for systemic therapy. Li AT, Xu JX, Blah TR, Lo SN, Saw RP, Varey AH, Van Akkooi A, Carlino MS, da Silva IP, Menzies AM, Shannon KF, Long GV, Scolyer RA, Thompson JF, Ch'ng S. J Am Acad Dermatol. 2024 Sep 5:S0190-9622(24)02768-3. doi: 10.1016/j.jaad.2024.06.107. Online ahead of print.PMID: 39243946

    3. Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas.Winder AA, Boyer Z, Ch'ng S, Stretch JR, Saw RPM, Shannon KF, Pennington TE, Nieweg OE, Varey AHR, Scolyer RA, Thompson JF, Cust AE, Lo SN, Spillane AJ, Smith AL. Ann Surg Oncol. 2024 May 27. doi: 10.1245/s10434-024-15456-w. Online ahead of print. PMID: 38802717

    4. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.  Stassen RC, Maas CCHM, van der Veldt AAM, Lo SN, Saw RPM, Varey AHR, Scolyer RA, Long GV, Thompson JF, Rutkowski P, Keilholz U, van Akkooi ACJ, Verhoef C, van Klaveren D, Grünhagen DJ. Lancet Oncol. 2024 Apr;25(4):509-517. doi: 10.1016/S1470-2045(24)00076-7. PMID: 38547894 Altmetric score: 23 (93rd centile) 6 citations

    5. Predicting Recurrence-Free and Overall Survival for Patients with Stage II Melanoma: The MIA Calculator.Varey AHR, Li I, El Sharouni MA, Simon J,, Dedeilia A, Ch’ng S, Saw RPM, Spillane AJ, Shannon KF, Pennington TE, Rtshiladze M, Stretch JR, Nieweg O, van Akkooi A, Sullivan RJ, Boland GM, Gershenwald JE,  van Diest PJ, Scolyer RA, Long GV, Thompson JF, Lo SN. J Clin Oncol. 2024 Apr 1;42(10):1169-1180. doi: 10.1200/JCO.23.01020. Epub 2024 Feb 5. PMID: 38315961 Altmetric score: 26 (94th centile) 6 citations  

    6. Population-based validation of the Melanoma Institute Australia (MIA) and the Memorial Sloan-Kettering Cancer Center (MSKCC) predictive tool for sentinel node status. Olofsson Bagge R, Mikiver R, Marchetti MA, Lo S, van Akkooi A, Coit DB, Ingvar C, Isaksson K, Scolyer R, Thompson J, Varey A, Lyth J, Bartlett EK. JAMA Surg, JAMA Surg. 2024 Mar 1;159(3):260-268. doi: 10.1001/jamasurg.2023.6904. PMID: 38198163 

    7. Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging. Gjorup CA, Woodford R, Li I, Carlino MS, Ch'ng S, Chung D, Hsiao E, Lo SN, London K, Long GV, Menzies AM, Nieweg OE, Pennington TE, Rtshiladze MA, Saw RPM, Scolyer RA, Shannon KF, Spillane AJ, Stretch JR, Thompson JF, Varey AHR, van Akkooi ACJ. Ann Surg Oncol. 2024 Mar;31(3):1857-1864. doi: 10.1245/s10434-023-14526-9. Epub 2023 Nov 15. PMID: 37966706 

    8. Does preoperative imaging for scalp non-melanocytic skin cancer accurately predict invasion of the cranial vault? A systematic review and meta-analysis. Rowse BM, Yu ACX, Faulkner H, Sandler G, Howle JR, Ch'ng S, Rao PJ, Varey AHR. ANZ J Surg. 2023 Jul-Aug;93(7-8):1970-1977. doi: 10.1111/ans.18566. Epub 2023 Jun 11. PMID: 37303266

    9. External validation in an Australian population of the EORTC-DeCOG nomogram predicting recurrence, distant metastasis and overall mortality in melanoma patients with positive sentinel lymph nodes. Li AT, Law J, Ch'ng S, Scolyer RA, Thompson JF, Lo SN, Varey AHR. Eur J Cancer. 2023 Aug;189:112901. doi: 10.1016/j.ejca.2023.04.017. Epub 2023 May 2. PMID: 37263897

    10. Ch’ng S, Varey AHR. Chapter 30: Melanoma, Gurtner: Principles of Plastic Surgery, Vol. 1; Neligan: Plastic Surgery, 5th ed.

    11. Has the advent of modern adjuvant systemic therapy for melanoma rendered sentinel node biopsy unnecessary? Varey AHR, Thompson JF, Howle JR, Lo SN, Ch'ng S, Carlino MS.Eur J Cancer. 2023 Jun;186:166-171. doi: 10.1016/j.ejca.2023.03.011. Epub 2023 Mar 17. PMID: 37080117 9 citations

    12. A novel approach to managing closed mallet finger injuries: The addition of a relative motion extension orthosis to a mallet orthosis in patients with proximal interphalangeal joint hyperextension. Odewahn N, Clark T, Varey A. J Hand Ther. 2023 Apr 8:S0894-1130(23)00004-2. doi: 10.1016/j.jht.2023.02.002. Online ahead of print. PMID: 37037727

    13. Development and validation of risk calculators for people with "thin" melanomas on their skin to predict the likelihood that their cancer will return: A Plain Language Summary. Sharouni ME, Lo SN, Varey AH, Elias SG, Witkamp AJ, Sigurdsson V, Suijkerbuijk KP, van Diest PJ, van Gils CH, Blokx WA, Scolyer RA, Thompson Future Oncol. 2023 Jan;19(2):97-102. doi: 10.2217/fon-2022-0525. Epub 2023 Feb 10. PMID: 36762595

    14. Vasopressors Improve Outcomes in Autologous Free Tissue Transfer: A Systematic Review and Meta-analysis. Noori O, Pereira J, Stamou D, Ch’ng S, Varey A. J Plast Reconstr Aesthet Surg. 2023 Jun;81:151-163. doi: 10.1016/j.bjps.2022.08.069. Epub 2022 Aug 27. PMID: 36379854

    15. Clinical management of melanocytic tumours of uncertain malignant potential (MelTUMPs), including melanocytomas: A systematic review and meta-analysis. Varey AHR, Williams GJ, Lo SN, Taing CY, Maurichi A, Santinami M, Scolyer RA, Thompson JF. J Eur Acad Dermatol Venereol. 2022 Oct 17. doi: 10.1111/jdv.18665. Online ahead of print. PMID: 36251355 4 citations

    16. Lack of association between anatomical sites of scalp melanomas and brain metastases does not support direct vascular spread. Li AT, Miin Yip J, Choksi H, London K, Potter AJ, Lo SN, Saw RPM, Shannon KF, Pires da Silva I, Varey AHR, Menzies AM, Long GV, Shivalingam B, Scolyer RA, Thompson JF, Ch'ng S. Melanoma Res. 2022 May 13. doi: 10.1097/CMR.0000000000000827. PMID: 35579680

    17. Benchmarking Survival Outcomes Following Surgical Management of pT3 and pT4 Cutaneous Squamous Cell Carcinoma of the Head and Neck. Yung AE, Crouch G, Varey AHR, Lo S, Elliott MS, Lee J, Rawson R, Gupta R, Hong AM, Clark JR, Ch'ng S.Ann Surg Oncol. 2022 Apr 13. doi: 10.1245/s10434-022-11669-z.PMID: 35419758 5 citations

    18. Management of Genital Hidradenitis Suppurativa and Lymphoedema with Restoration of Erectile Function. Allen N, Smith A, Curtin GP, Fernandez-Penas P, Varey AHR. Australas J Dermatol. 2022 Feb 9. doi: 10.1111/ajd.13796. PMID: 35138636 

    19. BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: Practical guidance for the Australian setting. Richard A. Scolyer, Victoria Atkinson, David E. Gyorki, Duncan Lambie, Sandra O'Toole, Robyn P.M. Saw, Benhur Amanuel, Christopher M. Angel, Alison E. Button-Sloan, Matteo S. Carlino, Sydney Ch'ng, Andrew J. Colebatch, Dariush Daneshvar, Ines Pires da Silva, Tamara Dawson, Peter M. Ferguson, Erwin Foster-Smith, Stephen B. Fox, Anthony J. Gill, Ruta Gupta, Michael Henderson, Angela M. Hong, Julie R. Howle, Louise A. Jackett, Craig James, C. Soon Lee, Alistair Lochhead, Daphne Loh, Grant A. McArthur, Catriona A. McLean, Alexander M. Menzies, Omgo E. Nieweg, Blake H. O'Brien, Thomas E. Pennington, Alison J. Potter, Saurabh Prakash, Robert V. Rawson, Rebecca L. Read, Michael A. Rtshiladze, Kerwin F. Shannon, B. Mark Smithers, Andrew J. Spillane, Jonathan R. Stretch, John F. Thompson, Paul Tucker, Alexander H. R. Varey, Ricardo E. Vilain, Benjamin A. Wood, Georgina V. Long. Pathology. 2021 Dec 19: S0031-3025(21)00533-X. doi:10.1016/j.pathol.2021.11.002.

    20. Merkel Cell Carcinoma in Situ: A Systematic Review of Prognosis and Management. Truong K, Goldinger S, Howle J, Veness M, Fernandez-Penas P, Varey AHR. Australas J Dermatol. 2021 Dec 7. DOI:10.1111/ajd.13758 – Top 10 most cited articles

    21. Melanoma management in the 21st century - a change in paradigm. Howle JR, Varey AHR, Carlino MS. ANZ J Surg. 2021 Dec;91(12):2557-2558. doi:10.1111/ans.17356. – Awarded ‘Top Downloaded Article’

    22. Survival outcomes of salvage metastasectomy after failure of modern-era systemic therapy for melanoma. Li AT, Vakharia K, Lo SN, Varey AHR, Carlino MS, Saw RPM, Shannon KF, Howle JR, Pennington TE, Stretch JR, Nieweg OE, Spillane AJ, Long GV, Menzies AM, Scolyer RA, Thompson JF, Ch’ng S. Ann Surg Oncol. 2021 Oct;28(11):6109-6123. doi: 10.1245/s10434-021-10489-x. 12 citations

    23. Stable and functional anatomical chest wall reconstruction using a novel prosthetic construct. Plastic Surgery Case Studies. Lendzion R, Varey AHR, Sandler G. Plastic Surgery Case Studies 2021; 7:1-3. doi: 10.1177/2513826X211022213

    24. Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies. Ch'ng S, Uyulmaz S, Carlino MS, Pennington TE, Shannon KF, Rtshiladze M, Stretch JR, Nieweg OE, Varey AHR, Hsiao E, Kapoor R, Pires da Silva I, Lo SN, Spillane AJ, Scolyer RA, Long GV, Hong AM, Saw RPM, Thompson JF, Menzies AM. Eur J Cancer, 2021 Jun 11;153:8-15. doi: 10.1016/j.ejca.2021.04.037. Online ahead of print. PMID: 34126335

    25. Predicting sentinel node positivity in melanoma patients: external validation of a risk-prediction calculator (the MIA nomogram) using a large European population-based patient cohort. El Sharouni MA, Varey AHR, Witkamp AJ, Ahmed T, Sigurdsson V, van Diest PJ, Scolyer RA, Thompson JF, Lo SN, van Gils CH. Br J Dermatol, 2021 Mar 3. doi: 10.1111/bjd.19895. 26 citations

    26. Validated Specialty Specific Models for Multi-Disciplinary Microsurgery Training Laboratories: A Systematic Review. Crouch G, Wong G, Hong J, Varey AHR, Solomon M, Bannon PG, McBride K, Ch’ng S. ANZ J Surg. 2021 Mar 15. doi: 10.1111/ans.16721.

    27. Development and validation of nomograms to predict local, regional, and distant recurrence in patients with thin (T1) melanomas. El Sharouni MA, Ahmed T, Varey AHR, Elias SG, Witkamp AJ, Sigurdsson V, Suijkerbuijk KPM, van Diest PJ, Scolyer RA, van Gils CH, Thompson JF, Blokx WAM, Lo SN. J Clin Oncol, 2021 Feb 18: JCO2002446. doi: 10.1200/JCO.20.02446. PMID: 33600211 35 citations Altmetric score: 9 (83rd centile)

    28. Thin Melanoma Recurrence Risk Prediction Tool. Lo SN, El Sharouni MA, Bab S, Scolyer RA, Thompson JF, Varey AHR. www.melanomarisk.org.au/ThinMelLand Feb 2021

    29. Desmoplastic Melanoma: A review of its pathology and clinical behaviour, and of management recommendations in published guidelines. Hughes TM, Williams GJ, Gyorki DE, Kelly JW, Stretch JR, Varey AHR, Hong AM, Scolyer RA, Thompson JF.  J Eur Acad Dermatol Venereol. 2021 Feb 5. doi: 10.1111/jdv.17154. 18 citations

    30. First Primary Melanoma Risk Prediction Tool. Lo SN, Jayaweera G, Martin L, Varey AHR, Cust AE. www.melanomarisk.org.au/FirstMelLand Sep 2020

    31. Subsequent Primary Melanoma Risk Prediction Tool. Lo SN, Jayaweera G, Martin L, Varey AHR, Cust AE. www.melanomarisk.org.au/SubMelLand Sep 2020

    32. An improved risk-prediction calculator for sentinel node positivity in melanoma patients: the MIA nomogram. Lo, SN, Ma J, Scolyer RA, Haydu LE, Stretch JR, Saw RPM, Nieweg OE, Shannon KF, Spillane AJ, Ch’ng S, Mann GJ, Gershenwald JE, Thompson JF, Varey AHR. J Clin Oncol, 2020 Aug 20;38(24):2719-2727. doi: 10.1200/JCO.19.02362 117 citations Altmetric score: 49 (96th centile)

    33. Sentinel Node Metastasis Risk Prediction Tool. Lo SN, Jayaweera G, Scolyer RA, Thompson JF, Varey AHR. https://www.melanomarisk.org.au/SNLLand Jun 2020 ~130,000 uses per year globally

    34. Australian general practitioners’ attitudes and knowledge of sentinel lymph node biopsy in melanoma management. Watts CG, Smith AL, Robinson S, Chang C, Schmid H, Goumas C, Kelly J, Hong A, Scolyer R, Long G, Spillane A, Henderson M, Gyorki D, Mar V, Morton RM, R Saw, Varey A, Mann GJ, Thompson J , Cust AE. Aust J Gen Pract, 2020 Jun;49(6):355-362

    35. Clinical Practice Guidelines for the diagnosis and management of Melanoma
      Melanocytic tumours of uncertain malignant potential. Varey A, Scolyer, R, Thompson, J. Cancer Council Australia Melanoma Guidelines Working Party. https://wiki.cancer.org.au/australiawiki/index.php?oldid=200058 2019.

    36. Use of a Six-Compartment volume Model to Quantifying Head Shape and measure the Outcomes of Spring Mediated Cranioplasty for Sagittal Synostosis. Liaw W, Parr WCH, Marucci DD, Peltz T, Varey A, Gianoutsos M, Walsh W. Plastic Reconstructive Surgery Global Open 2019 Apr;7(4):e2171.

    37. Melanoma Principles and Practice – A Comprehensive Guide Edition 2.0. Eds: Stretch JR, Varey AHR. Melanoma Institute Australia, 2018.

    38. Melanoma Essentials – A Concise Guide Edition 2.0. Eds Stretch JR, Varey AHR, Smith JR, Chakera AH. Melanoma Institute Australia, 2018.

    39. Clinical Practice Guidelines for the diagnosis and management of Melanoma
      Primary desmoplastic and neurotropic melanomas. Hughes T M, Gyorki D, Kelly, J, Stretch, J, Scolyer, R, Varey A, Hong A, Cancer Council Australia Melanoma Guidelines Working Party. https://wiki.cancer.org.au/australiawiki/index.php?oldid=186430, 2018

    40. Neurotropic melanoma: management guidelines based on clinicopathologic features, treatment and outcome of 671 patients. Varey AHR, Goumas C, Hong AM, Mann GJ, Fogarty GB, Stretch JR, Saw RPM, Spillane AJ, Shannon KF, Lee KJ, Quinn MJ, Thompson JF, Scolyer RA. Mod Path 2017 Nov;30(11):1538-1550. 43 citations

    41. Poor adherence to national clinical management guidelines; A population-based, cross-sectional study of the surgical management of melanoma in New South Wales, Australia. Varey AH, Madronio CM, Cust AE, Goumas C, Mann GJ, Armstrong BK, Scolyer RA, Curtin AM, Thompson JF. Ann Surg Oncol. 2017 Aug;24(8):2080-2088. 43 citations

    42. Early Detection of Ipilimumab-Induced Hypophysitis using FDG18-PET/ CT. Varey AH, Thompson JF. Austin J Dermatolog. 2016; 3(3): 1052.

    43. Melanoma Principles and Practice – A Comprehensive Guide. Eds: Stretch JR, Varey AHR. Melanoma Institute Australia, 2016. Co-author of 9 chapters.

    44. Preparation of the internal mammary vessels as recipients for free flap breast reconstruction. Dickson JK, Varey AHR, Wilson S. Ann R Coll Surg Engl. 2015 May; 97 (4), 318-318

    45. Melanoma Essentials – A Concise Guide Edition 1.0. Eds Stretch JR, Smith JR, Varey AHR, Chakera AH. Melanoma Institute Australia, 2015. Co-author of 5 chapters.

    46. Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance. Hamdollah Zadeh MA, Amin EM, Hoareau-Aveilla C, Domingo E, Symonds KE, Ye X, Heesom KJ, D’Silva O, Betteridge KB, Williams AC, Kerr DJ, Salmon AHJ, Oltean S, Midgley RS, Ladomery MR, Harper SJ, Varey AHR, Bates DO: Mol Oncol. 2015 Jan;9(1):167-78. 76 citations

    47. The distally pedicled gracilis flap for salvage of complex knee wounds. Mitsala G, Varey AHR, O’Neill JK, Chapman TW, Khan U. Injury. 2014 Nov;45(11):1776-81. 26 citations

    48. Association between VEGF Splice Isoforms and Progression-Free Survival in Metastatic Colorectal Cancer Patients Treated with Bevacizumab. Bates DO, Catalano PJ, Symonds KE, Varey AH, Ramani P, O’Dwyer PJ, Giantonio BJ, Meropol NJ, Benson AB, Harper SJ. Clin Cancer Res. 18(22):6384-91, Nov 2012. 86 citations Altmetric score: 16 (91stcentile)

    49. Vitamin D Deficiency in Burn Patients. Schumann AD, Paxton RL, Solanki NS, Kurmis RJ, Mackie IP, Varey AH, Greenwood JE. J Burn Care Res. 33(6):731-5, Nov 2012. 22 citations

    50. Periungual pilonidal sinus - a case report. Ngan P, Varey AHR, Mahajan AL. J Hand Surg Eur. J Hand Surg Eur, 36(2):155-7, Feb 2011.

    51. Thumb replantation using the reversed radial artery. Varey AHR, Patel I, Palmer JH. J Hand Surg Eur, 35(9):758-60, Nov 2010.

    52. Recombinant human VEGF165b inhibits choroidal neovascularisation. Hua J, Spee C, Kase S, Rennel ES, Magnussen A, Qiu Y, Varey A, Dhayade S, Churchill AJ, Harper SJ, Bates DO, Hinton DR. Invest Ophthalmol Vis Sci, 51(8):4282-8, Aug2010. 89 citations Altmetric score: 6 (75th centile)

    53. VEGF121b, a new member of the VEGFxxxb family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. Rennel ES, Varey AHR, Churchill AJ, Wheatley ER, Stewart L, Mather S, Bates DO, Harper SJ. Br J Cancer, 6;101(7):1183-93, Oct 2009. 78 citations

    54. Use of the A3 pulley as an interposition flap to cover periosteal defects. Varey AHR, Hughes JMF, Devaraj VS. J Hand Surg Eur, 34(4):542-3, Aug 2009.

    55. VEGF(165)b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Varey AH, Rennel ES, Qiu Y, Bevan HS, Perrin RM, Raffy S, Dixon AR, Paraskeva C, Zaccheo O, Hassan AB et al. Br J Cancer, 98(8):1366-79,2008. 275 citations Altmetric score: 12 (88th centile)

    56. Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma.Pritchard-Jones RO, Dunn DB, Qiu Y, Varey AH, Orlando A, Rigby H, Harper SJ and Bates DO. Br J Cancer, 97(2):223-30, 2007. 193 citations Altmetric score: 12 (88th centile)

    57. Treatment of loculated lactational breast abscess with a vacuum biopsy system. Varey AH, Shere MH and Cawthorn SJ. Br J Surg. 92(10):1225-6, Oct 2005. 29 citations

    58. Laparoscopic anterior resection and uterine manipulation: why make things difficult? Varey AHR, Darweish A, Pandey S and Dixon AR. Colorectal Disease, 7:104-5, Jan 2005.

    59. Effect of a 915-MHz simulated mobile phone signal on cognitive function in man. Preece AW, Iwi G, Davies-Smith A, Wesnes K, Butler S, Lim E and Varey A. Int J Radiat Biol. 75:447-56, Apr 1999. 481 citations Altmetric score: 9 (84th centile)

    1. Regarding sentinel lymph node biopsy in younger and older patients.
      Faries MB, Varey A, Elashoff DA, Lo S, Thompson JF. J Eur Acad Dermatol Venereol. 2024 Jun 1. doi: 10.1111/jdv.20162. Online ahead of print.PMID: 38822601

    2. Improved Survival with Sentinel Node Biopsy-An Emulated Randomized Controlled Trial. AHR Varey, RP Feser, NA Adegoke, RA Scolyer, JF Thompson, SN Lo. Annals of Surgical Oncology 31 (1), S34-S34

    3. An Externally Validated Online Tool To Calculate Personalized Probabilities Of Recurrence-Free And Overall-Survival In Stage II Melanoma Patients. AHR Varey, I Li, MA El Sharouni, J Simon, A Dedeilia, R Saw, A Spillane, et al. Annals of Surgical Oncology 31 (1), S32-S33

    4. ASO Visual Abstract: Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging. CA Gjorup, R Woodford, I Li, MS Carlino, S Ch’ng, D Chung, E Hsiao, ... A Varey, AC van Akkooi. Annals of Surgical Oncology 31 (3), 1882-1883

    5. Proteomic Profiling of Cutaneous Squamous Cell Carcinoma Samples from Solid Organ Transplant Recipients and Immunocompetent Patients. A Azimi, I Balot, J Kim, S Ch’ng, R Rawson, J Thompson, P Fernandez-Penas, A Varey. EJC Skin Cancer, Volume 2

    6. Survival Outcomes in T3N0 versus N1 in Head and Neck Cutaneous Squamous Cell Carcinoma–Implications for Neoadjuvant Immune Checkpoint Inhibitor Immunotherapy. AE Yung, YJ Jeong, AH Varey, SN Lo, R Gupta, R Wu, M Dunn, JH Lee, et al. EJC Skin Cancer, Volume 2

    7. Predicting sentinel node positivity in patients with primary cutaneous melanoma: an international multicentre study validating and refining the MIA risk calculator. AH Varey, C Gjorup, AH Chakera, LR Hölmich, M Moncrieff, AMK Ross, et al.. EJC Skin Cancer, Volume 2

    8. Validation of the Melanoma Institute Australia Prediction Tool for Sentinel Node Metastasis Risk Amongst Patients with Cutaneous Head and Neck Melanoma. AT Li, SN Lo, AH Varey, S Ch'ng. EJC Skin Cancer, Volume 2

    9. Analysis of the long-term survival of patients with thin melanomas using comprehensive, population-based Australian data. AH Varey, SN Lo, GJ Williams, AE Cust, D Ollila, RA Scolyer, et al..EJC Skin Cancer, Volume 2

    10. Long-term survival of melanoma patients according to primary tumour thickness–an Australian population-based study. AH Varey, SN Lo, GJ Williams, AE Cust, RA Scolyer, JF Thompson. EJC Skin Cancer, Volume 2

    11. Prediction of Sentinel Node Positivity Risk in Melanoma Patients: When Appropriate Statistical Methodology was Employed an i31-GEP Test Did Not Outperform a Tool that Uses Clinicopathologic Features Only. S Lo, A Varey, R Scolyer, J Thompson. SKIN The Journal of Cutaneous Medicine 7 (6), 1126-1130

    12. Knowledge of sentinel lymph node status improves accuracy when predicting melanoma mortality and selecting patients for adjuvant immunotherapy. Lo SN, Varey AHR, El Sharouni MA, Scolyer RA, Thompson JF. J Eur Acad Dermatol Venereol. 2023 Dec 26. doi: 10.1111/jdv.19709. Online ahead of print. PMID: 38147411 No abstract available.

    13. Online tools for predicting melanoma survival: including sentinel node status as a variable improves prediction accuracy. Lo, S. N., Varey, A. H., El Sharouni, M. A., Scolyer, R. A., & Thompson, J. F. J Eur Acad Dermatol Venereol. 2023 Sep 20. doi: 10.1111/jdv.19524. Online ahead of print. PMID: 37728525 

    14. 1120P Development and external validation of a clinical prediction model to predict recurrence-free survival and melanoma-specific survival in patients with melanoma after sentinel lymph node biopsy. RC Stassen, C Maas, AAM Van der Veldt, S Lo, R Saw, A Varey, R Scolyer, GV Long, J Thompson, P Rutkowski, U Keilholz, ACJ van Akkooi, C Verhoef, D van Klaveren, D Gruenhagen. Annals of Oncology 34, S674

    15. Population-based validation of the melanoma institute australia (MIA) and the memorial sloan-kettering cancer center (MSKCC) predictive tool for sentinel node status in patients with melanoma. Rasmus Mikiver, Roger Olofsson Bagge, Michael A Marchetti, Alexander Christopher Jonathan Van Akkooi, Daniel G Coit, Christian Ingvar, Karolin Isaksson, Richard A Scolyer, John Thompson, Alexander Varey, Johan Lyth, Edmund Bartlett. Journal of Clinical Oncology 41 (16_suppl), 9571-9571

    16. 805P Predicting recurrence-free survival for patients with stage II melanoma: A validated tool to guide selection for adjuvant systemic therapy. AHR Varey, MA El Sharouni, J Simon, JE Gershenwald, GV Long, RA Scolyer, JF Thompson, SN Lo. Annals of Oncology 33, S913

    17. 850P A dynamic recurrence risk prediction tool for adjuvant therapy in stage III melanoma. AM Taylor, C Galea, AHR Varey, KF Shannon, S Ch'ng, RPM Saw, TE Pennington, J Stretch, AJ Spillane, ACJ van Akkooi, I Pires da Silva, MS Carlino, RA Scolyer, GV Long, SN Lo, AM Menzies. Annals of Oncology 33, S939

    18. A tool to predict survival outcomes and guide adjuvant immunotherapy recommendations for patients with stage II melanoma. A Varey, GV Long, RA Scolyer, JE Gershenwald, J Simon, JF Thompson, SN Lo. Journal of Clinical Oncology 40 (16_suppl), e21556-e21556

    19. Predicting Sentinel Node Status in Patients With Melanoma: Does Gene Expression Profiling Improve Accuracy? Varey AH, Lo SN, Scolyer RA, Thompson JF. JCO Precision Oncology 2020; 4, 990-991.

    20. Letter on ‘Ausen K, Fossmark R, Spigset O, Pleym H. Randomized clinical trial of topical tranexamic acid after reduction mammoplasty. Varey AH, Lo SN. Br J Surg 2015; 102: 1348-1353.’ Br J Surg 2016 Jun.

    21. Malignant Melanoma Thickness and Risk of Future Malignancies. Young K, Ives A, Jones T, Verne J, Varey A, Ben-Shlomo Y. Plast Reconstr Surg. 2015 135 (5S), 31.

    22. Neurotropic Melanomas: Clinical Behavior and Radiotherapy Responsiveness. Varey AH, Hong AM, Stretch JR, Spillane AJ, Saw RP, Shannon K, Lee K, Thompson JF, Scolyer RA. Ann Surg Oncol. 2015 22, S127.

    23. Risk of Second Primary Malignancies Increases with Melanoma Breslow Thickness. Varey AH, Young KC, Ives A, Verne J, Thompson JF, Ben-Shlomo Y. Ann Surg Oncol. 2015 22, S120.

    24. Malignant Melanoma Thickness and Risk of Future Malignancies. Young K, Ives A, Jones T, Verne J, Varey A, Ben-Shlomo Y. Plast Reconstr Surg. 2014 134 (2), 386.

    25. Letter on ‘Soft-Tissue Reconstruction of Open Fractures of the Lower Limb: Muscle versus Fasciocutaneous Flaps’. Varey AH, Khan U. Plast Reconstr Surg. 2013 Mar;131(3):448e.

    26. Letter on ‘Angiogenesis and Plastic Surgery’. Varey AH, Dunn DBA. J Plast Reconstr Aesthet Surg. 2009 May;62(5):710.

    27. TIA-1 an RNA binding protein, upregulates the anti-angiogenic isoform of VEGF in colon cancer cells. Hamdollah-Zadeh MA, Varey AH, Nowak DG, Williams AC, Malik K, Paraskeva C, Bates DO. Microcirculation, 15(7):657, Oct 2008.

    28. VEGF121b is anti-angiogenic in cancer and eye disease. Rennel ES, Varey AHR, Churchill AJ, Harper SJ, Bates DO. Microcirculation, 15(7):638, Oct 2008.

    29. The anti-angiogenic to pro-angiogenic VEGF switch is intrinsic to malignant transformation in colon carcinoma. Varey A, Kaidi A, Paraskeva C, Harper S, Bates D. www.ncri.org.uk/ncriconference/archive/2007/abstracts/pdf/B84.pdf

    30. Bevacizumab does not inhibit growth of LS174t tumors overexpressing VEGF165b. Varey AHR, Rennel ES, Harper SJ, Bates DO. Microcirculation, 14(6):637, Aug 2007.

    31. The Vascular Endothelial Growth Factor (VEGF) isoform VEGF165b binds VEGFR-1 but does not transduce a signal in vitro. Bevan HS, Varey AHR, Harper SJ, Bates DO. Microcirculation, 14(6):661, Aug 2007.

    32. Improving the targeting of bevacizumab therapy for colorectal carcinoma. Varey AHR, Rennel ES, Harper SJ, Bates DO. Proceedings of the American Association for Cancer Research Annual Meeting, 48:967, Apr 2007. Cited for inclusion in Genentech’s Annual Report of most important publications/presentations in 2007.

    33. binds pro-angiogenic VEGF165 and anti-angiogenic VEGF 165b with similar affinities. Varey AHR, Qiu Y, Dixon AR, Harper SJ, Bates DO. Avastin Microcirculation,13(6):511-34, Sep 2006.

    34. Splice factor regulation of VEGF isoform expression. Woolard J, Varey A, Nowak DG, Ladomery M, Harper SJ, Bates DO. Microcirculation, 13(6):511-34, Sep 2006.

    35. Anti-angiogenic VEGF-A Isoforms are Endogenous to Normal Colon and Can Inhibit Colorectal Carcinoma Growth In Vivo. Varey AHR, Rennel ES, Harper SJ, Bates DO, Dixon AR. Colorectal Disease, 8 (s2):99-102, Jul 2006.

    36. Inhibitory VEGF splice variants in colorectal carcinoma. Varey AHR, Dixon AR, Harper SJ, Bates DO. Ann R Coll Surg Engl, 88(1):73, Jan 2006.

    37. VEGF165b can inhibit colorectal cancer growth in vivo. Varey AHR, Rennel ES, Dixon AR, Harper SJ, Bates DO. www.med.miami.edu/mnbws/06PUBLICATIONS.html (2006)

    38. VEGF165b inhibits growth of vascular but not poorly vascularised tumours. Varey AHR, Dixon AR, Waine L, Pritchard Jones RO, Harper SJ Bates DO. Colorectal Disease 7(s1): 144-151, Jul 2005.

  • Designer/Programmer (>37,000 downloads)

    63. Picturing-MD. Dickson JD, Varey AHR. Apple App Store 2015.

    64. PicturingMed. Dickson JD, Varey AHR. Apple App Store 2011

    65. PicturingSyndromes. Dickson JD, Varey AHR. Apple App Store 2011

    66. Leg Fractures. Varey AHR. Apple App Store 2011

    67. PicturingED. Dickson JD, Varey AHR. Apple App Store 2011